BioPharma Credit PLC LEXICON PHARMACEUTICALS PREPAYMENT (5195Y)
10 September 2020 - 1:00AM
UK Regulatory
TIDMBPCR
RNS Number : 5195Y
BioPharma Credit PLC
09 September 2020
9 september 2020
BioPharma Credit plc
(the "Company")
LEXICON Pharmaceuticals PREPAYMENT
Pharmakon Advisors, the Investment Manager of BioPharma Credit
PLC (the "Company"), notes that Lexicon Pharmaceuticals ("Lexicon")
has repaid in full its $150 million secured term loan, of which the
Company owned $124.5 million. As a result of the repayment, the
Company received $132.3 million today from Lexicon, comprised of
$124.5 million in principal, $2.2 million in accrued interest and
$5.6 million in make-whole amount and prepayment fees. This
investment generated an IRR of 12.1%.
Enquiries
BioPharma Credit plc
via Link Company Matters Limited
Company Secretary
+44 (0)1392 477 500
Buchanan
+44 (0)20 7466 5000 / biopharmacredit@buchanan.uk.com
David Rydell
Mark Court
Jamie Hooper
Henry Wilson
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCFLFEVATIAIII
(END) Dow Jones Newswires
September 09, 2020 11:00 ET (15:00 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2024 to May 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From May 2023 to May 2024